SOT 65th Annual Meeting and ToxExpo 2026
San Diego Convention Center, San Diego, CA
March 22, 2026 - March 25, 2026The SOT Annual Meeting and ToxExpo brings together a global community of toxicologists and scientists from related disciplines. Visit us at booth #1143 and browse our resources below to learn about our HepatoXcell™ primary human hepatocytes, peripheral blood mononuclear cells (PBMCs), hTERT-immortalized cells, and primary cells that support predictive drug development and toxicity testing.
Would you like to speak to one of ATCC’s representatives about a product or service? Make an appointment with us so we can discuss your needs.
Primary human hepatocytes are considered the gold standard for in vitro liver models due to their high predictive value in drug metabolism and toxicity studies. They can provide early insights into how a drug will behave in the human body, potentially reducing the risk of adverse effects in clinical trials. ATCC hepatocytes are meticulously isolated and characterized to ensure the highest quality and performance for your drug development and toxicity testing needs. Try our HepatoXcell™ primary human hepatocytes and media today!
Learn moreContact us today
Your ATCC sales representative stands ready to discuss your research needs and provide you with personalized care. Please complete our form to let us know how we can help, and we will start working on your needs right away.
